As a featured speaker at the AMEC conference, entitled "Unsilencing the Unheard and the Underserved," Dr. Garrett-Bakelman addressed vital issues concerning SNMA member's education and health disparities. Topics covered included potential paths to be taken to become a physician-scientist; career options post graduate training; and approaches to work-life balance.
Dr. Andrew I. Schafer gave the Keynote Address at the spring meeting of the Royal College of Physicians in London on Feb. 27, 2015, to an audience that included HRH Princess Anne. In his address, Dr. Schafer talked about the future of academic medicine, comparing and contrasting the situations in the U.S. and the United Kingdom and Europe, in areas such as medical education and research funding. Following the lecture, the Academy of Medical Sciences of England sponsored a series of brief...
Membership to the AAP is a coveted honor and reflects remarkable dedication to the advancement of scientific and practical medicine. Founded in 1885 as a non-profit professional organization, the AAP has some 1,300 active members and 600 honorary members.
Dr. Richard T. Silver has dedicated his efforts for many decades to finding a cure for Myeloproliferative Neoplasms (MPNs) and chronic myeloid leukemia, while bringing the best in patient care and scientific advancement to the clinical setting. MPNs are a group of diseases related to the excessive production of bone marrow cells.
Dr. Lewis C. Cantley, Professor of Cancer Biology in Medicine and the Margaret and Herman Sokol Professor in Oncology Research, has been elected to the Institute of Medicine. This is a highly prestigious honor for Dr. Cantley, who is the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine.
In an advance that could eventually offer patients with blood disorders curative therapies derived from their own cells, researchers at the Ansary Stem Cell Institute, WCMC, have been able to directly reprogram vascular cells to long-lasting blood cells that resemble bone marrow stem cells capable of forming the various components of blood necessary for life.
The 23rd Annual Department of Medicine Awards were announced on June 17, 2014. This award is presented annually to members of the Weill Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research. It is supported by the Michael Wolk Foundation.
Initiated in 2002, the Fellow Award in Research is presented annually to fellows within the Weill Department of Medicine who have presented outstanding research. This year's finalists were announced at the June 10 Medicine Grand Rounds (12th Annual).
Dr. Andrew I. Schafer is an expert in the research and treatment of myeloproliferative neoplasms (MPNs) and a world-renowned physician-scientist in hematology and medical oncology. As Director of the Richard T. Silver, MD, Myeloproliferative Neoplasm Center, he will manage both the biomedical research and clinical activities surrounding MPNs.
Dr. Richard Furman, Division of Hematology & Medical Oncology, and co-authors have published a landmark paper in the New England Journal of Medicine. Their results utilizing the drug, Idelalisib, in a randomized, double-blinded study (5 countries) suggest that a common form of leukemia may be treated without toxic chemotherapy.
